Cognition Therapeutics Announces Participation in Upcoming September Conferences
August 30, 2023 08:00 ET
|
Cognition Therapeutics, Inc.
PURCHASE, N.Y., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage neuroscience company developing drugs that treat neurodegenerative disorders by...
Athira Pharma Presents Phase 2 Clinical Data Correlating Improvements in Biomarkers of Neurodegeneration and Neuroinflammation with Improvements in Measures of Cognition and Function in Alzheimer’s Disease
July 17, 2023 07:00 ET
|
Athira Pharma, Inc.
New preclinical data demonstrate neuroprotective effects of fosgonimeton in models of amyloid-ß-mediated toxicity In preclinical models, ATH-1105 protects against pathologies common to amyotrophic...
DAVOS ALZHEIMER’S COLLABORATIVE SHARES ADVANCEMENT OF PREPARING HEALTHCARE SYSTEMS AND INCLUSIVE RESEARCH AT THE 2023 AAIC
July 12, 2023 19:15 ET
|
Davos Alzheimer's Collaborative
New York, NY, July 12, 2023 (GLOBE NEWSWIRE) -- DAC Healthcare System Preparedness poster presentations geared for timely detection from mobilizing community workers, adding pharmacies to the...
The Joint Commission, in Collaboration with the Alzheimer’s Association, Launches Memory Care Certification for Assisted Living Communities
July 11, 2023 12:30 ET
|
The Joint Commission
OAKBROOK TERRACE, Ill., July 11, 2023 (GLOBE NEWSWIRE) -- The Joint Commission, in collaboration with the Alzheimer’s Association, launched Memory Care Certification for Assisted Living Communities...
UsAgainstAlzheimer’s Applauds FDA Approval of Leqembi for Treatment of Early-Stage Alzheimer’s
July 06, 2023 17:35 ET
|
UsAgainstAlzheimer's
Washington, DC, July 06, 2023 (GLOBE NEWSWIRE) -- Patient advocacy organization UsAgainstAlzheimer’s today hailed the first-of-its-kind traditional approval by the Food and Drug Administration (FDA)...
Collaborative AAPA, PA Foundation, Cleveland Clinic Alzheimer’s Early Detection Project Moves into Pilot Phase
June 28, 2023 10:59 ET
|
American Academy of PAs
Alexandria, VA, June 28, 2023 (GLOBE NEWSWIRE) -- Last year, the American Academy of PAs (AAPA), the PA Foundation, and Cleveland Clinic were awarded a grant from the Davos Alzheimer’s Collaborative...
DAVOS ALZHEIMER'S COLLABORATIVE HOSTS GLOBAL MEETING ON THE POWER OF HEALTH TECHNOLOGY FOR ALZHEIMER'S
May 31, 2023 18:13 ET
|
Davos Alzheimer's Collaborative
New York, NY, May 31, 2023 (GLOBE NEWSWIRE) -- The Davos Alzheimer’s Collaborative (DAC) will hold the fourth meeting of its Healthcare System Preparedness Learning Laboratory “The Power of...
Neuronic and Santa Clara University partner to develop next-gen neurotech for photobiomodulation guided by real-time brain activity
May 11, 2023 12:00 ET
|
Neuronic Devices Operations GmbH
Integrating photobiomodulation with neurofeedback will revolutionize treatment of brain disorders SANTA CLARA, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Neuronic, a multi-national company focused...
Brain Health Academy Enrollment is Now Open, First Session Launches May 17
April 24, 2023 11:05 ET
|
UsAgainstAlzheimer's
Washington, DC, April 24, 2023 (GLOBE NEWSWIRE) -- Following the launch of its highly successful Brain Health Academy in 2022, UsAgainstAlzheimer’s today announced class will be back in session...
Silo Pharma to Present at Psychedelic Drug Development Conference
April 24, 2023 08:15 ET
|
Silo Pharma, Inc.
ENGLEWOOD CLIFFS, NJ, April 24, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional...